entertainment -WSS

entertainment

author：knowledge 2025-09-27 22:57:08 - browse：38718

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Cancer cells are shown to suck energy source from immune cells

hotspot

focus

hotspot

WSS

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Medicare to cover more brain scans related to Alzheimer’s drugs

Researchers CRISPR chickens in bid to protect them from bird flu

A bus careens into a gulch in southern Mexico, leaving 27 people dead

A revolution in caring for preterm infants

Wikipedia

entertainment

focus

Psychedelics group wrestles with new pharma identity

Nick Jonas talks about managing diabetes along with his career

Drug repurposing or repositioning? The language matters

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

Activists slam private health insurers over coverage restrictions

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

New air purifier tech could be key to improving indoor air quality

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

Dobbs anniversary: the lost opportunity of abortion as health care

A bus careens into a gulch in southern Mexico, leaving 27 people dead

focus

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

STAT Readout: Today's biotech news includes Sana and Amylyx

Akero's treatment for NASH falls short in cirrhosis study

China dismisses criticism of top diplomat's comments appearing to push for race

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

hotspot

focus

hotspot

Wikipedia